학술논문

Fulvestrant with or without anti-HER2 therapy in patients in a postmenopausal hormonal state and with ER-positive HER2-positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG-C06)
Document Type
Article
Source
In: Cancer Medicine. (Cancer Medicine, September 2023, 12(17):17718-17730)
Subject
Language
English
ISSN
20457634